60
Participants
Start Date
May 29, 2025
Primary Completion Date
December 30, 2025
Study Completion Date
December 30, 2025
cymactive™ catheter device (CCD)
"The cymactive™ catheter (manufactured by Ingenion Medical Ltd) received CE marking on the 28th March 2024, as a Class IIb device (n. ECM24MDR002 rev.0, Single Registration Number (SRN) of the Manufacturer UK-MF-000041065) and will be available in the UK market, subject to local arrangements.~The cymactive™ catheter is designed to remain in situ for up to 30 days, does not extend outside the patient's body except for 2 removal strings, and has an integral, magnetically controlled valve that allows the user to control their own urination. The study participant will each be supplied with a magnetic Actuator (a separate Class I device supplied by Ingenion Medical) so they are in control of valve and their own voiding. The magnet is strong and care will need to be taken to keep it at least 6 inches from magnetically-sensitive items, i.e. mobile phones, laptops and credit cards. Study participants should also avoid contact with MRI machines."
Foley-type catheter device
Routine standard of care. Usually replaced \~ 3 monthly
RECRUITING
Addenbrookes Hospital - Cambridge University Hospitals NHS Foundation Trust, Cambridge
RECRUITING
Royal Devon & Exeter Hospital - Royal Devon University Healthcare NHS Trust, Exeter
RECRUITING
Ipswich Hospital - East Suffolk and North Essex NHS Foundation Trust, Ipswich
RECRUITING
Frimley Park Hospital - Frimley Health NHS Foundation Trust, Camberley
RECRUITING
Southmead Hospital - North Bristol NHS Trust,, Bristol
Ingenion Medical Limited
INDUSTRY